Cellular prion protein protects from inflammatory and neuropathic pain

Molecular Pain

Volumn 7, Issue , 2011, Pages

  Gadotti, Vinicius M ^a   Zamponi, Gerald W ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Knockout mice; NMDA receptor; Pain; Prion protein; Spinal cord

Indexed keywords

CELL PROTEIN; DIZOCILPINE; FORMALDEHYDE; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PRION PROTEIN; N METHYLASPARTIC ACID; NEUROPROTECTIVE AGENT; PRNP PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BITE; CONTROLLED STUDY; INFLAMMATION; INFLAMMATORY PAIN; LICKING; MALE; MECHANICAL STIMULATION; MOUSE; MOUSE STRAIN; NERVE LIGATION; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PAIN; PAIN THRESHOLD; PAW EDEMA; PRIORITY JOURNAL; SCIATIC NERVE; SENSITIZATION; SIGNAL TRANSDUCTION; SPINAL CORD DORSAL HORN; THERMAL STIMULATION; WILD TYPE; ANIMAL; C57BL MOUSE; DRUG EFFECT; METABOLISM; NEURALGIA; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PRION; STIMULATION;

ANIMALS; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; N-METHYLASPARTATE; NEURALGIA; NEUROPROTECTIVE AGENTS; NOCICEPTION; PAIN THRESHOLD; PHYSICAL STIMULATION; PRIONS;

EID: 80051620194     PISSN: None     EISSN: 17448069     Source Type: Journal    
DOI: 10.1186/1744-8069-7-59     Document Type: Article

References (53)

1. Yaksh TL. Regulation of spinal nociceptive processing: where we went when we wandered onto the path marked by the gate. Pain 1999, 6:149-152.
2. Hill RG. Molecular basis for the perception of pain. Neuroscientist 2001, 7:282-292. 10.1177/107385840100700405, 11488394.
3. Jackson DL, Graff CB, Richardson JD, Hargreaves KM. Glutamate participates in the peripheral modulation of thermal hyperalgesia in rats. Eur J Pharmacol 1995, 284:321-325. 10.1016/0014-2999(95)00449-U, 8666015.
4. Larsson M. Ionotropic glutamate receptors in spinal nociceptive processing. Mol Neurobiol 2009, 40:260-288. 10.1007/s12035-009-8086-8, 19876771.
5. Minami T, Matsumura S, Okuda-Ashitaka E, Shimamoto K, Sakimura K, Mishina M, Mori H, Ito S. Characterization of the glutamatergic system for induction and maintenance of allodynia. Brain Res 2001, 895:178-185. 10.1016/S0006-8993(01)02069-8, 11259776.
6. Carlton SM, Coggeshall RE. Inflammation-induced changes in peripheral glutamate receptor populations. Brain Res 1999, 820:63-70. 10.1016/S0006-8993(98)01328-6, 10023031.
7. Nakanishi O, Ishikawa T, Imamura Y. Modulation of formalin-evoked hyperalgesia by intrathecal N-type Ca channel and protein kinase C inhibitor in the rat. Cell Mol Neurobiol 1999, 19:191-197. 10.1023/A:1006937209676, 10081603.
8. Berrino L, Oliva P, Massimo F, Aurilio C, Maione S, Grella A, Rossi F. Antinociceptive effect in mice of intraperitoneal N-methyl-D-aspartate receptor antagonists in the formalin test. Eur J Pain 2003, 7:131-137. 10.1016/S1090-3801(02)00086-1, 12600794.
9. Villetti G, Bergamaschi M, Bassani F, Bolzoni PT, Maiorino M, Pietra C, Rondelli I, Chamiot-Clerc P, Simonato M, Barbieri M. Antinociceptive activity of the N-methyl-D-aspartate receptor antagonist N-(2-Indanyl)-glycinamide hydrochloride (CHF3381) in experimental models of inflammatory and neuropathic pain. J Pharmacol Exp Ther 2003, 306:804-814. 10.1124/jpet.103.050039, 12750440.
10. Wiech K, Kiefer RT, Töpfner S, Preissl H, Braun C, Unertl K, Flor H, Birbaumer N. A placebo-controlled randomized crossover trial of the N-methyl-D-aspartic acid receptor antagonist, memantine, in patients with chronic phantom limb pain. Anesth Analg 2004, 98:408-413.
11. Chizh BA. Novel approaches to targeting glutamate receptors for the treatment of chronic pain. Amino Acids 2002, 23:169-176. 10.1007/s00726-001-0124-4, 12373533.
12. Millan MJ. The induction of pain: an integrative review. Prog Neurobiol 1999, 57:1-164. 10.1016/S0301-0082(98)00048-3, 9987804.
13. Yu XM, Askalan R, Keil GJ, Salter MW. NMDA channel regulation by channel-associated protein tyrosine kinase Src. Science 1997, 275:674-678. 10.1126/science.275.5300.674, 9005855.
14. Gladding CM, Raymond LA. Mechanisms underlying NMDA receptor synaptic/extrasynaptic distribution and function. Mol Cell Neurosci
15. Khosravani H, Zhang Y, Tsutsui S, Hameed S, Altier C, Hamid J, Chen L, Villemaire M, Ali Z, Jirik FR, Zamponi GW. Prion protein attenuates excitotoxicity by inhibiting NMDA receptors. J Cell Biol 2008, 181:551-565. 10.1083/jcb.200711002, 2364707, 18443219.
16. Gadotti VM, Bonfield SP, Zamponi GW. Depressive-like behaviour of mice lacking cellular prion protein. Behav Brain Res
17. Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain 2009, 10:895-926. 10.1016/j.jpain.2009.06.012, 2750819, 19712899.
18. Woolf CJ, Salter MW. Neuronal plasticity: Increasing the gain in pain. Science 2000, 288:1765-1769. 10.1126/science.288.5472.1765, 10846153.
19. Herrero JF, Laird JM, López-García JA. Wind-up of spinal cord neurones and pain sensation: much ado about something?. Prog Neurobiol 2000, 61:169-203. 10.1016/S0301-0082(99)00051-9, 10704997.
20. Casals-Díaz L, Vivó M, Navarro X. Nociceptive responses and spinal plastic changes of afferent C-fibers in three neuropathic pain models induced by sciatic nerve injury in the rat. Exp Neurol 2009, 217:84-95. 10.1016/j.expneurol.2009.01.014, 19416675.
21. Yoshimura M, Yonehara N. Alteration in sensitivity of ionotropic glutamate receptors and tachykinin receptors in spinal cord contribute to development and maintenance of nerve injury-evoked neuropathic pain. Neurosci Res 2006, 56:21-28. 10.1016/j.neures.2006.04.015, 16901566.
22. Zhou Q, Price DD, Callam CS, Woodruff MA, Verne GN. Effects of the N-methyl-D-aspartate receptor on temporal summation of second pain (wind-up) in irritable bowel syndrome. J Pain 2011, 12:297-303. 10.1016/j.jpain.2010.09.002, 21146468.
23. Paszcuk AF, Gadotti VM, Tibola D, Quintão NL, Rodrigues AL, Calixto JB, Santos AR. Anti-hypernociceptive properties of agmatine in persistent inflammatory and neuropathic models of pain in mice. Brain Res 2007, 23:124-133.
24. Khosravani H, Zhang Y, Zamponi GW. Cellular prion protein null mice display normal AMPA receptor mediated long term depression. Prion 2008, 2:48-50. 10.4161/pri.2.2.6628, 2634516, 19098438.
25. Davidson EM, Coggeshall RE, Carlton SM. Peripheral NMDA and non-NMDA glutamate receptors contribute to nociceptive behaviors in the rat formalin test. Neuroreport 1997, 8:941-946. 10.1097/00001756-199703030-00025, 9141069.
26. Beirith A, Santos ARS, Calixto JB. Mechanisms underlying the nociception and paw oedema caused by injection of glutamate into the mouse paw. Brain Res 2002, 924:219-228. 10.1016/S0006-8993(01)03240-1, 11750907.
27. Beirith A, Santos ARS, Calixto JB. The role of neuropeptides and capsaicin sensitive fibres in glutamate-induced nociception and paw oedema in mice. Brain Res 2003, 969:110-116. 10.1016/S0006-8993(03)02286-8, 12676371.
28. Ji RR, Rupp F. Phosphorylation of transcription factor CREB in rat spinal cord after formalin-induced hyperalgesia: relationship to c-fos induction. J Neurosci 1997, 17:1776-1785.
29. Santos ARS, Gadotti VM, Oliveira GL, Tibola D, Paszcuk AF, Neto A, Spindola HM, Souza MM, Rodrigues ALS, Calixto JB. Mechanisms involved in the antinociception caused by agmatine in mice. Neuropharmacology 2005, 48:1021-1034. 10.1016/j.neuropharm.2005.01.012, 15857629.
30. Davis AM, Inturrisi CE. Attenuation of hyperalgesia by LY235959, a competitive N-methyl-D-aspartate receptor antagonist. Brain Res 2001, 894:150-153. 10.1016/S0006-8993(00)03325-4, 11245826.
31. Li TT, Ren WH, Xiao X, Nan J, Cheng LZ, Zhang XH, Zhao ZQ, Zhang YQ. NMDA NR2A and NR2B receptors in the rostral anterior cingulate cortex contribute to pain-related aversion in male rats. Pain 2009, 146:183-193. 10.1016/j.pain.2009.07.027, 2764121, 19695778.
32. Quartaroli M, Carignani C, Dal Forno G, Mugnaini M, Ugolini A, Arban R, Bettelini L, Maraia G, Belardetti F, Reggiani A, Trist DG, Ratti E, Di Fabio R, Corsi M. Potent antihyperalgesic activity without tolerance produced by glycine site antagonist of N-methyl-D-aspartate receptor GV196771A. J Pharmacol Exp Ther 1999, 290:158-169.
33. Svendsen F, Tjølsen A, Rygh LJ, Hole K. Expression of long-term potentiation in single wide dynamic range neurons in the rat is sensitive to blockade of glutamate receptors. Neurosci Lett 1999, 259:25-28. 10.1016/S0304-3940(98)00884-2, 10027547.
34. Suzuki R, Matthews EA, Dickenson AH. Comparison of the effects of MK-801, ketamine and memantine on responses of spinal dorsal horn neurones in a rat model of mononeuropathy. Pain 2001, 91:101-109. 10.1016/S0304-3959(00)00423-1, 11240082.
35. Kalliomäki J, Granmo M, Schouenborg J. Spinal NMDA-receptor dependent amplification of nociceptive transmission to rat primary somatosensory cortex (SI). Pain 2003, 104:195-200. 10.1016/S0304-3959(03)00002-2, 12855329.
36. Meotti FC, Carqueja CL, Gadotti VM, Tasca CI, Walz R, Santos AR. Involvement of cellular prion protein in the nociceptive response in mice. Brain Res 2007, 1151:84-90.
37. Martins VR, Beraldo FH, Hajj GN, Lopes MH, Lee KS, Prado MM, Linden R. Prion protein: orchestrating neurotrophic activities. Curr Issues Mol Biol 2010, 12:63-86.
38. Zamponi GW, Stys PK. Role of prions in neuroprotection and neurodegeneration: a mechanism involving glutamate receptors?. Prion 2009, 3:187-189. 10.4161/pri.3.4.9549, 2807689, 19684483.
39. Lapergue B, Demeret S, Denys V, Laplanche JL, Galanaud D, Verny M, Sazdovitch V, Baulac M, Haïk S, Hauw JJ, Bolgert F, Brandel JP, Navarro V. Sporadic Creutzfeldt-Jakob disease mimicking nonconvulsive status epilepticus. Neurology 2010, 74:1995-1999. 10.1212/WNL.0b013e3181e39703, 20445151.
40. Ratté S, Vreugdenhil M, Boult JK, Patel A, Asante EA, Collinge J, Jefferys JG. Threshold for epileptiform activity is elevated in prion knockout mice. Neuroscience 2011, 179:56-61.
41. Prusiner SB. Prion diseases and the BSE crisis. Science 1997, 278:245-251. 10.1126/science.278.5336.245, 9323196.
42. Prusiner SB. Prions. Proc Natl Acad Sci USA 1998, 95:13363-13383. 10.1073/pnas.95.23.13363, 33918, 9811807.
43. Colby DW, Prusiner SB. Prions. Cold Spring Harb Perspect Biol 2011,
44. Muller WE, Ushijima H, Schroder HC, Forrest JM, Schatton WF, Rytik PG, Heffner-Lauc M. Cytoprotective effect of NMDA receptor antagonists on prion protein (PrionSc)-induced toxicity in rat cortical cell cultures. Eur J Pharmacol 1993, 246:261-267. 10.1016/0922-4106(93)90040-G, 7901042.
45. Spencer MD, Knight RS, Will RG. First hundred cases of variant Creutzfeldt-Jakob disease: retrospective case note review of early psychiatric and neurological features. BMJ 2002, 324:1479-1482. 10.1136/bmj.324.7352.1479, 116442, 12077031.
46. Macleod MA, Stewart GE, Zeidler M, Will R, Knight R. Sensory features of variant Creutzfeldt-Jakob disease. J Neurol 2002, 249:706-711. 10.1007/s00415-002-0696-2, 12111303.
47. Reichman O, Tselis A, Kupsky WJ, Sobel JD. Onset of vulvodynia in a woman ultimately diagnosed with Creutzfeldt-Jakob disease. Obstet Gynecol 2010, 115:423-425. 10.1097/AOG.0b013e3181b80294, 20093867.
48. Bueler H, Fischer M, Lang Y, Bluethmann H, Lipp HP, DeArmond SJ, Prusiner SB, Aguet M, Weissmann C. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 1992, 356:577-582. 10.1038/356577a0, 1373228.
49. Dubuisson D, Dennis SG. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 1977, 4:161-74.
50. Hunskaar S, Hole K. The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain 1987, 30:103-114. 10.1016/0304-3959(87)90088-1, 3614974.
51. Tjølsen A, Hole K. Animal Models of Analgesia. The Pharmacology of Pain 2001, 130:1-20. Springer-Verlag, Berlin.
52. Hylden JL, Wilcox GL. Intrathecal morphine in mice: a new technique. Eur J Pharmacol 1980, 67:313-316. 10.1016/0014-2999(80)90515-4, 6893963.
53. Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988, 33:87-107. 10.1016/0304-3959(88)90209-6, 2837713.